A deep learning radiomics model for predicting non-sentinel lymph node metastases in early-stage breast cancer patients.

AIMS: To develop and validate a deep learning radiomics model to predict non-sentinel lymph node (NSLN) metastases in early-stage breast cancer patients with 1-2 positive sentinel lymph node (SLN) metastases.

METHODS

This retrospective and prospective study encompassed 1,647 patients. Clinical, pathological information, and axillary ultrasound (AUS) findings, collected. Radiomic features of breast cancer lesions were extracted from the ultrasound images. We developed predictive models based on clinical factors alone (C model), clinical factors coupled with AUS (CA model), and clinical factors integrated with both AUS and radiomic features (CAR model). The predictive performance of each model was evaluated via the area under the curve (AUC), decision curve analysis (DCA), and calibration curve analysis.

RESULTS

The AUC values for the C model, CA model and CAR model in the test cohort were 0.812, 0.850, and 0.994, respectively. Notably, the CAR model exhibited significantly superior predictive capability compared to both the C model and CA model. In subgroups analyses, the CAR model also achieved the optimal predictive performance. The DCA curve confirmed that the CAR model possessed significant clinical implications.

CONCLUSIONS

The CAR model had the capability to predict NSLN metastases in early-stage breast cancer with 1-2 positive SLN metastases.